Fc gamma receptor iib in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathways

HIGHLIGHTS

• who: . and collaborators from the Shaanxi Normal, China have published the paper: Fc gamma receptor IIb in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathways, in the Journal: (JOURNAL)
• what: Finding a promising therapeutic strategy and providing more efficient treatment options to patients with recurrent GBM have become the primary goals of oncologists. The authors show that various immune-related signaling pathways are enriched in recurrent GBM using an RNA-Seq database from the Chinese Glioma Genome Atlas (CGGA). The analysis showed that the mRNA expression . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.